Kassenzulassung von Nichtinvasiven Pränatalen Tests (NIPTs)
GMS Zeitschrift für Hebammenwissenschaft; 8:Doc01 · 10.06.2021 · 1-1
DOI: 10.3205/zhwi000020 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Zeitschrift für Hebammenwissenschaft; 8:Doc01, erschienen am 10.06.2021. Verfasst von Skeide und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In its position paper on statutory health insurance coverage of what is referred to as noninvasive prenatal testing (NIPT), the German Society of Midwifery Science (DGHWi) argues for the tests to be covered by statutory health insurance as this would also ensure the necessary government monitoring and psychosocial and medical advice and support. At the same time, the DGHWi urges for structural measures to be taken to support the statutory health insurance coverage of NIPT. These include, most importantly, comprehensive government support for families of children with special needs. Health insurance coverage of NIPT must also be accompanied by extensive social science research to facilitate a better understanding of this complex technology and its ethical, political and social implications.
Schlagwörter
Zitieren
APA
Skeide, A., Tegethoff, D., Beckmann, L., Schlüter-Cruse, M., Fü, D.-G., (DGHWi), & R.-H.-E.-V. (2021). Kassenzulassung von Nichtinvasiven Pränatalen Tests (NIPTs). GMS Zeitschrift für Hebammenwissenschaft; 8:Doc01, 1-1. https://doi.org/10.3205/zhwi000020
Vancouver
Skeide, A., Tegethoff, D., Beckmann, L., et al. Kassenzulassung von Nichtinvasiven Pränatalen Tests (NIPTs). GMS Zeitschrift für Hebammenwissenschaft; 8:Doc01. 2021:1-1. doi:10.3205/zhwi000020
BibTeX
@article{Skeide2021,
author = {Skeide and A. and Tegethoff and D. and Beckmann and L. and Schlüter-Cruse and M. and Fü and D.-G. and (DGHWi) and R.-H.-E.-V.},
title = {Kassenzulassung von Nichtinvasiven Pränatalen Tests (NIPTs)},
journal = {GMS Zeitschrift für Hebammenwissenschaft; 8:Doc01},
year = {2021},
pages = {1--1},
doi = {10.3205/zhwi000020}
}
EUVIMED